Aldeyra Therapeutics Inc (NAS:ALDX)
$ 4.82 -0.08 (-1.63%) Market Cap: 287.03 Mil Enterprise Value: 194.66 Mil PE Ratio: 0 PB Ratio: 3.37 GF Score: 41/100

Q3 2021 Aldeyra Therapeutics Inc Earnings Call Transcript

Oct 28, 2021 / 12:00PM GMT
Release Date Price: $9 (+9.22%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) I would now like to hand over the conference to the company's Chief Financial Officer, Mr. Joshua Reed. Please go ahead, sir.

Joshua Reed
Aldeyra Therapeutics, Inc. - CFO

Good morning, everyone. With me is Dr. Todd Brady, President and Chief Executive Officer of Aldeyra. This morning, we issued a press release reporting our financial results for the quarter ended September 30, 2021. A copy of the press release is available on the investors and media section of our website, www.aldeyra.com. Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra.

Forward-looking statements include statements regarding submission of potential new drug applications, potential commercialization, the anticipated timing of results from our clinical trials,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot